These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33875335)

  • 1. Is sugammadex superior to neostigmine in reversing rocuronium-induced neuromuscular blockade?
    Bartlett E; Urman RD; Urits I; Kaye AD; Viswanath O
    J Clin Anesth; 2022 Aug; 79():110288. PubMed ID: 33875335
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.
    Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K
    Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of sugammadex versus neostigmine on restoration of neuromuscular function in surgical patients with myasthenia gravis undergoing rocuronium-induced neuromuscular blockade: a systematic review protocol.
    Yellott E; Badeaux J; Martin J; Schiavo JH
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):1922-1928. PubMed ID: 30335038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
    Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
    BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation.
    Deana C; Barbariol F; D'Incà S; Pompei L; Rocca GD
    BMC Anesthesiol; 2020 Mar; 20(1):70. PubMed ID: 32213163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
    Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
    Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery.
    Oh TK; Ryu JH; Nam S; Oh AY
    BMC Anesthesiol; 2020 Feb; 20(1):41. PubMed ID: 32079528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J; San Miguel G; García V; Pelegrín F
    Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery.
    Togioka BM; Yanez D; Aziz MF; Higgins JR; Tekkali P; Treggiari MM
    Br J Anaesth; 2020 May; 124(5):553-561. PubMed ID: 32139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
    Broens SJL; Boon M; Martini CH; Niesters M; van Velzen M; Aarts LPHJ; Dahan A
    Anesthesiology; 2019 Sep; 131(3):467-476. PubMed ID: 31045894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.